NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:00-14:07 |
Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE after Biliary Drainage: TEMP Score |
Wen-Zhe Fan | The First Affiliated Hospital, Sun Yat-Sen University, China |
2 | 14:07-14:14 |
Thermosensitive Nanogel: A Novel Embolic Agent of TACE for HCC |
Rong Ding | Yunnan Provincial Cancer Hospital, China |
3 | 14:14-14:21 |
Effect of AFP and PIVKA-II Secretion Status on Prognosis of Advanced HCC Patients Receiving TACE plus Systemic Therapies |
Jin-Feng Bai | Yunnan Provincial Cancer Hospital, China |
4 | 14:21-14:28 |
TACE Combined with Systemic Therapy for Unresectable Liver Cancer |
Ning Ai | The Fourth Hospital of Hebei Medical University, China |
5 | 14:28-14:35 |
TACE and TKIs with or without PD-1 as First-line Treatment for Unresectable HCC: A Propensity Score Matching Study |
Xue-Gang Yang | Sichuan Cancer Hospital & Institute, China |
6 | 14:35-14:42 |
MWA vs. RFA Combined with Vertebroplasty for Vertebral Metastatic Tumors: A Retrospective Cohort Study |
Fu-An Wang | Jiangsu Subei People's Hospital, China |
7 | 14:42-15:00 |
Panelists
Hai-Dong Zhu
Zhongda Hospital, Southeast University, China /
Alex Tang
Subang Jaya Medical Centre,Malaysia /
Wen-Zhe Fan
The First Affiliated Hospital, Sun Yat-Sen University, China /
Rong Ding
Yunnan Provincial Cancer Hospital, China /
Jin-Feng Bai
Yunnan Provincial Cancer Hospital, China /
Ning Ai
The Fourth Hospital of Hebei Medical University, China /
Xue-Gang Yang
Sichuan Cancer Hospital & Institute, China /
Fu-An Wang
Jiangsu Subei People's Hospital, China /
Jian-Bo Zhao
Southern Hospital of Southern Medical University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 15:00-15:07 |
Fruquintinib Combined with Sintilimab plus TACE for Unresectable HCC: A Single-arm Phase 2 Study |
Hui Zeng | Zhejiang Provincial Cancer Hospital, China |
2 | 15:07-15:14 |
Predictive Model of Unresectable HCC Treated with TACE-HAIC Combined with TKIs and ICIs |
Li-Nan Yin | Harbin Medical Univisity Cancer Hospital, China |
3 | 15:14-15:21 |
Transformation of IR Workflow through Smart Operating Room Development: Technological Integration and Clinical Practice |
Lin Zhu | Zhongshan Hospital Affiliated with Fudan University, China |
4 | 15:21-15:28 |
Can Commonly Used Large Language Models Be Recommend Interventional Therapy to Liver Cancer Patients? |
Zhi-Hui Chang | Shengjing Hospital of China Medical University, China |
5 | 15:28-15:35 |
Association between TACE Refractoriness and Prognosis in Chinese Patients with HCC: A Retrospective Cohort Study |
Qin-Xue Sun | Ningbo Medical Center Li Huili Hospital, China |
6 | 15:35-16:00 |
Panelists
Hyun Ki Yoon
Asan Medical Center, University of Ulsan College of Medicine, Korea /
Prijo Sidipratomo
Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Indonesia /
Hui Zeng
Zhejiang Provincial Cancer Hospital, China /
Li-Nan Yin
Harbin Medical Univisity Cancer Hospital, China /
Lin Zhu
Zhongshan Hospital Affiliated with Fudan University, China /
Zhi-Hui Chang
Shengjing Hospital of China Medical University, China /
Qin-Xue Sun
Ningbo Medical Center Li Huili Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:10 |
Passing the Torch Mentoring Program: Introduction |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
2 | 16:10-16:20 |
Passing the Torch Mentoring Program: Leading Mission I |
Hang Yuan | Henan Cancer Hospital, China |
3 | 16:20-16:30 |
Passing the Torch Mentoring Program: Leading Mission II |
Bing-Jie Zheng | Henan Cancer Hospital, China |
4 | 16:30-16:40 |
Passing the Torch Mentoring Program: Leading Mission IIIa |
Hang Yuan | Henan Cancer Hospital, China |
5 | 16:40-16:50 |
Passing the Torch Mentoring Program: Leading Mission IIIb |
Shi-Jun Xu | Henan Cancer Hospital, China |
6 | 16:50-17:00 |
Passing the Torch Mentoring Program: Leading Mission IV |
Hong-Tao Hu | Henan Cancer Hospital, China |
7 | 17:00-17:10 |
Passing the Torch Mentoring Program: Leading Mission V |
Xi Li | The Fifth Affiliated Hospital of Sun Yat-sen University, China |
8 | 17:10-17:20 |
Passing the Torch Mentoring Program: Leading Mission VI |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
9 | 17:20-18:00 |
Q & A and Panel Discussion (Overcoming Miscommunication & Shaping the Future)
Jiaywei Tsauo
Guangdong Provincial People's Hospital, China /
Bin-Yan Zhong
Zhejiang Cancer Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:00-14:30 |
How to Get Your Paper Published |
Jiaywei Tsauo | Guangdong Provincial People's Hospital, China |
2 | 14:30-14:45 |
The Art of Transforming Ideas into Scientific Investigations |
Bin-Yan Zhong | Zhejiang Cancer Hospital, China |
3 | 14:45-15:00 |
How I Updated My Writing Skills after Publishing My First Paper |
Chu-Hui Zeng | Zhongda Hospital, Southeast University, China |
4 | 15:00-15:15 |
Top Five Reasons for Writing Scientific Papers |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
5 | 15:15-15:55 |
Panelist
Ho-Young Song
Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China /
Jiaywei Tsauo
Guangdong Provincial People's Hospital, China /
Chu-Hui Zeng
Zhongda Hospital, Southeast University, China /
Bin-Yan Zhong
Zhejiang Cancer Hospital, China /
Jian Lu
Zhongda Hospital, Southeast University, China /
Xi Li
The Fifth Affiliated Hospital of Sun Yat-sen University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:12 |
Sequential TACE and PVE before Right Pemihepatectomy in Patients with HCC |
Hyun Ki Yoon | Asan Medical Center, University of Ulsan College of Medicine, Korea |
2 | 16:12-16:24 |
Surgical Treatment of HCC with Portal Vein Tumor Thrombus - Progress and Perspectives |
Shu-Qun Cheng | Eastern Hepatobiliary Surgery Hospital, China |
3 | 16:24-16:36 |
TARE for Unresected HCC with Portal Vein Invasion: Which Patient to Treat? |
Ajit K. Yadav | Sir Ganga Ram Hospital, Delhi, India |
4 | 16:36-16:48 |
Precision Radiotherapy and Immune-targeted Therapeutic Strategies in Hepatocellular Carcinoma |
Wei-Hu Wang | Beijing Cancer Hospital, China |
5 | 16:48-17:00 |
ICIs and Anti-VEGF Antibody/TKIs with or without TACE as First-line Treatment for Advanced HCC (CHANCE2201): A Target Trial Emulation Study |
Hai-Tao Zhao | Peking Union Medical College Hospital, China |
6 | 17:00-17:12 |
A Nationwide Target Trial Emulation on the Treatment of Patients with HCC and Main Trunk PVTT Using 125I Irradiation Stents and Combined Therapeutic Approaches (PATENCY II) |
Jian Lu | Zhongda Hospital, Southeast University, China |
7 | 17:12-17:30 |
Panelists
Flavio G. Rocha
Oregon Health and Science University, USA /
Hyun Ki Yoon
Asan Medical Center, University of Ulsan College of Medicine, Korea /
Shu-Qun Cheng
Eastern Hepatobiliary Surgery Hospital, China /
Ajit K. Yadav
Sir Ganga Ram Hospital, Delhi, India /
Wei-Hu Wang
Beijing Cancer Hospital, China /
Hai-Tao Zhao
Peking Union Medical College Hospital, China /
Jian Lu
Zhongda Hospital, Southeast University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:00-14:05 |
Opening Remarks
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
2 | 14:05-14:20 |
NEJM and Clinical Research |
Rui-Ping Xiao | Associate Editor, New England Journal of Medicine, China |
3 | 14:20-14:35 |
Why and How to Publish on Med-X Journal? |
Lisa X. Xu | Editors-in-Chief, Med-X, China |
4 | 14:35-14:50 |
Trends and Prospects of Sustainable Growth in STTT |
Qiu Sun | Editor, Signal Transduction and Targeted Therapy, China |
5 | 14:50-15:05 |
The Innovation Journals: Serving Global Reserchers |
Ke Chen | Executive Director, The Innovation, China |
6 | 15:05-15:15 |
Introduction to EngMedicine |
Fu-Gen Wu | Southeast University, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 15:15-15:55 |
Increasing the Proportion of International Submissions |
||
2 | 15:15-15:55 |
Enhancing the Quality of Submissions |
||
3 | 15:15-15:55 |
Improving Citation Rates and Journal Visibility |
||
4 | 15:55-16:00 |
Summary
Xiao-Long Qi
Zhongda Hospital Southeast University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:36 |
The Value of 40 KeV Virtual Monoenergetic Imaging in Preoperative Assessment for Precision TACE in Hepatocellular Carcinoma |
Shuang Li | Zhongda Hospital, Southeast University, China |
2 | 13:36-13:42 |
Efficacy and Safety of Adebrelimab (A PD-L1 Inhibitor) plus Bevacizumab (A VEGF-A-targeting Inhibitor) in Combination with Hepatic Artery Infusion Chemotherapy for Advanced Stage Hepatocellular Carcinoma: A Retrospective Cohort Study |
Chen Li | Sun Yat-sen University Cancer Center, China |
3 | 13:42-13:48 |
A Comparison of Treatment Outcome of Hepatocellular Carcinoma in Caudate Lobe, between Thermal Ablation and Transarterial Chemoembolization: A Retrospective Review |
Sahutchadech Tangisarapap | Roi-Et hospital, Thailand |
4 | 13:48-13:54 |
Efficacy of Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Gallbladder |
Batmunkh Erdenebulgan | Second state central hospital, Mongolia |
5 | 13:54-14:00 |
Percutaneous Cholangioscopy and Fluoroscopy-guided Forceps Biopsy for Pathologically Diagnosing Highly Suspected Perihilar Malignant Diseases: A Retrospective Cohort Study |
Xiang-Yu Yang | Beijing Chao-Yang Hospital, Capital Medical University, China |
6 | 14:00-14:06 |
A Prospective, Single-Arm, Phase 2 Study of Transarterial Embolization plus Hepatic Arterial Infusion Chemotherapy Combined with Sequential Lenvatinib and Sintilimab in Patients with Infiltrative Hepatocellular Carcinoma. |
Ying-Wen Hou | Sun Yat-sen University Cancer Center, China |
7 | 14:06-14:12 |
Efficacy and Safety of TACE Combined with TKI against TACE Alone for Managing Intermediate-stage HCC with Hypovascular Nodules |
Jun Yang | The First Affiliated Hospital of Soochow University, China |
8 | 14:12-14:18 |
First-line Durvalumab with Arterial Chemotherapy in Major Portal Invaded Hepatocellular Carcinoma: the Phase 2 DurHope Study with Biomolecular Analyses |
Ming Zhao | Sun Yat-sen Cancer Center, China |
9 | 14:18-14:24 |
The Prognostic Value of Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio for Liver Tumours after Image-guided Irreversible Electroporation |
Vinson Chan | University of Leeds, United Kingdom |
10 | 14:24-14:30 |
Early Response Evaluation of Hepatocellular Carcinoma After Transarterial Chemoembolization Using Triphasic Computed Tomography |
Nasr ullah Yaqoob | INDUS HOSPITAL KARACHI PAKISTAN, Pakistan |
11 | 14:30-14:36 |
Transarterial Chemoembolization plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-risk Locations |
Guilin Zhang | Wuhan Union Hospital, Huazhong University of Science and Technology, China |
12 | 14:36-14:42 |
Hepatic Arterial Infusion Chemotherapy Combined with Toripalimab and Surufatinib in the Treatment of Advanced Intrahepatic Cholangiocarcinoma |
Songlin Song | Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital, China |
13 | 14:42-14:48 |
Complications of Interventional Treatment for Vascular Tumors and Vascular Malformations: Mechanisms of Occurrence, Treatment Strategies and Prevention |
Qi Wang | Guangdong Provincial People's Hospital, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 15:00-15:06 |
TACE Combined with Immunotherapy plus Targeted Therapy after 125I Irradiation Stent Placement in HCC with Main Portal Vein Tumor Thrombosis: A Nationwide Target Trial Emulation Study (PATENCY II) |
Jun-Hao Mei | Zhongda Hosiptal, China |
2 | 15:06-15:12 |
Development and Validation of Mean Platelet Volume-Based Predictive Model for Early TACE Failure/Refractoriness in Unresectable Hepatocellular Carcinoma: A Real-World Retrospective Cohort Study |
Hai-Rui Wang | Shengjing Hospital of China Medical University, China |
3 | 15:12-15:18 |
Optimal Thermal Ablation Margin Range Model for Liver Malignancies ≤3 cm Based on 979 Cases |
Zhen-Kang Qiu | Sun Yat-sen University Cancer Center, China |
4 | 15:18-15:24 |
Locoregional Therapy Combined with Systemic Therapy (LRT + ST) for Unresectable and Metastatic Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-analysis |
Zhen-Kang Qiu | Sun Yat-sen University Cancer Center, China |
5 | 15:24-15:30 |
Successful Preoperative Transcatheter Arterial Embolization Significantly Reduces Intraoperative Bleeding in Juvenile Nasopharyngeal Angiofibroma without the Need for Embolization of Internal Carotid Artery Branches: A Case Report of Two Patients |
Stephen Kurniawan | Dr. Cipto Mangunkusumo Hospital-Faculty of Medicine Universitas Indonesia |
6 | 15:30-15:36 |
Lenvatinib plus Hepatic Arterial Infusion Chemotherapy of FOLFOX versus Lenvatinib Alone for Advanced Hepatocellular Carcinoma |
Qi-Cong Mai | Guangdong Provincial People's Hospital, China |
7 | 15:36-15:42 |
Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma : A Bibliometric and Knowledge-map Analysis |
Yu-Qing Xu | Tianjin Medical University Cancer Institute & Hospital,National Clinical Research Center for Cancer, China |
8 | 15:42-15:48 |
Study on the Role of Pirfenidone in Liver Fibrosis - Hepatocellular Carcinoma |
Shuai Zhang | The Affiliated Hospital of Guizhou Medical, China |
9 | 15:48-15:54 |
Hyaluronidase Additional to Transarterial Chemoembolization Improves Efficacy for Liver Cancer: Preclinical Evaluation |
Dan Zhao | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China |
10 | 15:54-16:00 |
Transarterial Chemoembolisation and Tyrosine Kinase Inhibitors with or without Programmed Death-1 Inhibitors as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study |
Xue-Gang Yang | Sichuan Cancer Hospital & Institute, China |
11 | 16:00-16:06 |
Temperature‑sensitive Liquid Embolic Agent Transarterial Chemoembolization (TempSLE-TACE) versus D-TACE for Unresectable Hepatocellular Carcinoma(u-HCC): A Multicenter Retrospective Propensity Score Study in China |
Qingyun Xie | Liver Transplantation Center, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, China |
12 | 16:06-16:12 |
Superselective Ablative Chemo-ethanol Embolization for Recurrent Single Hepatocellular Carcinoma |
Kun Yung Kim | Seoul National University Bundang Hospital, Korea |
13 | 16:12-16:18 |
Efficacy and Prognostic Factors of COVID-19 Vaccine in Patients with Hepatocellular Carcinoma: Analysis of Data from A Prospective Cohort Study |
He Zhao | National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China |
14 | 16:18-16:24 |
HAIC Combined with Sindilizumab and Bevacizumab for the Treatment of Advanced HCC: An Exploratory Clinical Study |
Zizhuo Wang | Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital, China |
15 | 16:24-16:30 |
Integrated Machine Learning Identifies SPP1hi Macrophages Marker Genes for Predicting Therapeutic Response of TACE in HCC |
Zi-Lin Wang | Zhejiang University School of Medicine, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:30-16:36 |
Fruquintinib Combined with Sintilimab plus Transarterial Chemoembolization (TACE) for Unresectable Hepatocellular Carcinoma (uHCC): A Single-arm Phase Ⅱ Study |
Hui Zeng | Zhejiang Provincial Cancer Hospital, China |
2 | 16:36-16:42 |
Effect of AFP and PIVKA-II Secretion Status on Prognosis of Advanced Hepatocellular Carcinoma Patients Receiving TACE Combined with Systemic Therapies |
Jin-Feng Bai | Yunnan Provincial Cancer Hospital, China |
3 | 16:42-16:48 |
Revolutionizing Detection and Ablation of Invisible Liver Metastases Post-Chemotherapy in Colorectal Cancer: the Role of Transcatheter CT Hepatic Arteriography |
Hang Yuan | Henan Cancer Hospital, China |
4 | 16:48-16:54 |
Yttrium-90 Radioactive Microspheres: Adverse Reactions and Complications of Transcatheter Arterial Radioembolization in the Treatment of Malignant Liver Tumors |
Meng-Di Qi | China Medical University, China |
5 | 16:54-17:00 |
A Study on the Contribution of LSM11 to the Outcome of Radiotherapy in Hepatocellular Carcinoma Cells |
Wen-Yi Jiang | Peking University Cancer Hospital, China |
6 | 17:00-17:06 |
Safety and Technical Feasibility of Modified Percutaneous Transesophageal Enterostomy (PTEE) in Cancer Patients Ineligible for Conventional Gastrostomy |
Ji Hoon Shin | Asan Medical Cente, University of Ulsan College of Medicine, Korea |
7 | 17:06-17:12 |
In Which Tumor Burden Range Does Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors Perform Better than the Combination of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors? A Comparative Analysis of Their Efficacy and Safety in Advanced-stage Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus, Using Propensity Score Matching |
Jia-Xi Liu | The First Hospital of China Medical University, China |
8 | 17:12-17:18 |
Combined Biliary Iodine-125 Brachytherapy and Stent Implantation in Malignant Obstructive Jaundice: A Prognostic Model for Survival Outcomes |
Hui-Yi sun | Interventional Therapy at Zhongshan Hospital, Fudan University, China |
9 | 17:18-17:24 |
CT-guided Celiac Plexus Neurolysis in the Management of Visceral Intractable Pain in Patients with Advanced Cancer |
Tai Tan Nguyen | Nhan Dan Gia Dinh Hospital, Vietnam |
10 | 17:24-17:30 |
Radioactive Iodine-125 Particle Implantation Combined with Transarterial Chemoinfusion and Synchronous Immune Checkpoint Inhibitors for the Management of Locally Advanced Pancreatic Cancer: A Retrospective Single-center Analysis |
Bin Li | Beijing Hospital, China |
11 | 17:30-17:36 |
CT-guided Percutaneous Cryoablation in Patients with Lung Nodules Mainly Composed of Ground-Glass Opacities |
Li-Zhi Niu | Guangzhou Fuda Cancer Hospital, China |
12 | 17:36-17:42 |
The Effect and Mechanism of Iodine 125 Seeds in Combination with Curcumin in Non-Small Cell Lung Cancer |
Zi-Tong Chen | Children's Hospital Alfiliated to Shandong University, China |
13 | 17:42-17:48 |
Ablative Therapy for Residual Lesions After First-Line Treatment of Locally Advanced Unresectable Lung Adenocarcinoma: A Prospective, Randomized Controlled Study |
Feng Xian | Sichuan Cancer Hospital, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 08:00-08:20 |
Precision Treatment of Triple Negative Breast Cancer |
Zhi-Min Shao | Fudan University Affiliated Cancer Hospital, China |
2 | 08:20-08:40 |
Use of Artificial Intelligence for Imaging and Therapy of HCC |
Julius Chapiro | Yale School of Medicine, USA |
3 | 08:40-09:00 |
Application of Ultra Resolution Microscopy in Tumor Diagnosis and Treatment |
Ping Liang | Chinese PLA General Hospital, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 09:35-09:55 |
Gastroduodenal Stents: Evolution and Future Perspectives |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 10:00-10:20 |
Advancement of Combined Locoregional Therapy with Immunotherapy in HCC |
Gao-Jun Teng | Zhongda Hospital, Southeast University, China |
2 | 10:20-10:40 |
New Horizons of Liver Tumor Treatment |
David C. Madoff | Yale School of Medicine, USA |
3 | 10:40-11:00 |
Multimodal Thermal Therapy for Solid Tumor: A New Interventional Immunomodulatory |
Lisa X. Xu | Shanghai Jiao Tong University, China |
4 | 11:00-11:20 |
Preclinical and Clinical Histotripsy for the Treatment of Liver Cancer |
Maggie (Man) Zhang | University of Michigan, USA |
5 | 11:20-11:40 |
Research on the Mechanisms of Cancer Cachexia and Drug Development |
Rui-Ping Xiao | Peking University, China |
6 | 11:40-12:00 |
Discussion |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 12:30-12:35 |
Opening Remarks
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
2 | 12:35-12:40 |
Experts Speech
Lian-Xin Liu
The First Affiliated Hospital of University of Science and Technology of China /
Ming Kuang
The First Affiliated Hospital, Sun Yat-Sen University, China /
Hua Xiang
Hunan Cancer Hospital, China /
Guo-Hong Han
Xi'an International Medical Center Hospital, China /
Zhong-Min Wang
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China
|
||
3 | 12:40-12:55 |
Structured Research, Limitless Innovation |
Masatoshi Kudo | Kindai University Faculty of Medicine, Japan |
4 | 12:55-13:10 |
laparoscopic liver resection for liver cance |
Lian-Xin Liu | The First Affiliated Hospital of University of Science and Technology of China |
5 | 13:10-13:25 |
Panelists
Masatoshi Kudo
Kindai University Faculty of Medicine, Japan /
Tian-Qiang Song
Tianjin Medical University Cancer Institute & Hospital, China /
Hai-Tao Zhao
Peking Union Medical College Hospital, China /
Hai-Bo Shao
The First Affiliated Hospital of China Meical University, China /
Jia-Ping Li
The First Affiliated Hospital of Sun Yat-sen University, China /
Ming Zhao
Sun Yat-Sen University Cancer Center, China /
Hai-Peng Yu
Tianjin Medical University Cancer Institute & Hospital, China /
Jian Lu
Zhongda Hospital, Southeast University, China /
Bin-Yan Zhong
Zhejiang Cancer Hospital, China /
Wen-Zhe Fan
The First Affiliated Hospital, Sun Yat-Sen University, China
|
||
6 | 13:25-13:30 |
Summary
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:42 |
Role of Y90 Radioembolization in Treatment of Large HCCs |
Rickie Lik-Fai Cheng | Princess Margaret Hospital, Hong Kong, China |
2 | 13:42-13:54 |
Combination of TACE with Systemic Therapy for Unresectable HCC |
Zhen-Wei Peng | The First Affiliated Hospital, Sun Yat-Sen University, China |
3 | 13:54-14:06 |
Advanced Forearm Access for Same Day Radiation Segmentectomy |
Uei Pua | Tan Tock Seng Hospital, Singapore |
4 | 14:06-14:18 |
How to Provide More Surgical Opportunities for Patients with HCC Using Minimal Invasive Methods to Increase the Remnant Liver Volume |
Lian-Xin Liu | The First Affiliated Hospital of University of Science and Technology of China |
5 | 14:18-14:30 |
Panelists
Tao Peng
The First Affiliated Hospital of Guangxi Medical University, China /
Ji Hoon Shin
Asan Medical Cente, University of Ulsan College of Medicine, Korea /
Rickie Lik-Fai Cheng
Princess Margaret Hospital, Hong Kong, China /
Zhen-Wei Peng
The First Affiliated Hospital, Sun Yat-Sen University, China /
Uei Pua
Tan Tock Seng Hospital, Singapore /
Lian-Xin Liu
The First Affiliated Hospital of University of Science and Technology of China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:30-14:42 |
Combining TACE with Checkpoint Inhibitors for Intermediate-stage HCC |
David C. Madoff | Yale School of Medicine, USA |
2 | 14:42-14:54 |
How to Select 2nd-line Systemic Therapy in Advanced-stage HCC? |
Masatoshi Kudo | Kindai University Faculty of Medicine, Japan |
3 | 14:54-15:06 |
First-line TACE with ICIs and VEGF or TKIs for Intermediate-stage HCC: A Target Trial Emulation Study |
Hai-Dong Zhu | Zhongda Hospital, Southeast University, China |
4 | 15:06-15:18 |
Is Systemic Therapy Alone Sufficient as Standard Treatment for Advanced Stage HCC? |
Xiao-Dong Wang | Beijing Cancer Hospital, China |
5 | 15:18-15:30 |
Panelists
Wan-Guang Zhang
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China /
David C. Madoff
Yale School of Medicine, USA /
Masatoshi Kudo
Kindai University Faculty of Medicine, Japan /
Hai-Dong Zhu
Zhongda Hospital, Southeast University, China /
Xiao-Dong Wang
Beijing Cancer Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:12 |
Hepatopancreatoduodenectomy for Widespread Hilar Cholangiocarcinoma |
Kiyoshi Hasegawa | Graduate School of Medicine, The University of Tokyo Hospital, Japan |
2 | 16:12-16:24 |
Surgical and Multidisciplinary Treatment of Intrahepatic Cholangiocarcinoma |
Feng Shen | Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China |
3 | 16:24-16:36 |
Intervention for Biliary Malignancy |
Seung Boo Yang | Nowon Eulji University Hospital, Korea |
4 | 16:36-16:48 |
Neoadjuvant Therapy for BTC — A Medical Oncologist's Perspective |
Yuan Cheng | Jinling Hospital, Nanjing University, China |
5 | 16:48-17:00 |
Panelists
Lian-Xin Liu
The First Affiliated Hospital of University of Science and Technology of China /
Hai-Tao Zhao
Peking Union Medical College Hospital, China /
Kiyoshi Hasegawa
Graduate School of Medicine, The University of Tokyo Hospital, Japan /
Feng Shen
Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China /
Seung Boo Yang
Nowon Eulji University Hospital, Korea /
Yuan Cheng
Jinling Hospital, Nanjing University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 17:00-17:12 |
Percutaneous Biliary Metallic Stent Insertion in Patients with Malignant Duodenobiliary Obstruction: Outcomes and Factors Influencing Biliary Stent Patency |
Hyun Ki Yoon | Asan Medical Center, University of Ulsan College of Medicine, Korea |
2 | 17:12-17:24 |
Research Progress and Challenges in Mucosal Melanoma of the Head and Neck |
Wei Guo | Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, China |
3 | 17:24-17:36 |
The Value of Integrated Angiography and CT Scan System for Oncologic Interventions |
Kiang Hiong Tay | Singapore General Hospital, Singapore |
4 | 17:36-17:48 |
Same Day Percutaneous Renal Cryoablation : A New Paradigm to Enhancing Patient Care? |
Jun-Jian Huang | Emory University school of medicine, USA |
5 | 17:48-18:00 |
Cool Approach, Clear Result: Lung Cryoablation in Clinical Practice |
Somrach Thamtorawat | Faculty of Medicine Siriraj Hospital, Thailand |
6 | 18:00-18:15 |
Panelists
Alex Tang
Subang Jaya Medical Centre,Malaysia /
Wei-Qian Chen
Zhejiang Lishui Central Hospital, China /
Hyun Ki Yoon
Asan Medical Center, University of Ulsan College of Medicine, Korea /
Wei Guo
Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, China /
Kiang Hiong Tay
Singapore General Hospital, Singapore /
Jun-Jian Huang
Emory University school of medicine, USA /
Somrach Thamtorawat
Faculty of Medicine Siriraj Hospital, Thailand
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:42 |
Trans-arterial Approach for Treatment of Primary Lung Cancer |
Shinichi Hori | Institute for Image Guided Therapy, Japan |
2 | 13:42-13:54 |
Bronchial Artery Embolization in Hemoptysis: Is Glue Better than PVA? |
Ajit K. Yadav | Sir Ganga Ram Hospital, Delhi, India |
3 | 13:54-14:06 |
Lung Neoplasms—the Role of TACP, TPCE Combined with Thermoablation: Long-term Evaluation |
Thomas J. Vogl | University Hospital Frankfurt, Johann Wolfgang Goethe University, Germany |
4 | 14:06-14:18 |
Current Status of Clinical Application of SBRT in Lung Tumors |
Ya-Ping Xu | Shanghai Pulmonary Hospital, China |
5 | 14:18-14:30 |
Panelists
Xiao-Li Zhu
The First Affiliated Hospital of Soochow University, China /
Shinichi Hori
Institute for Image Guided Therapy, Japan /
Ajit K. Yadav
Sir Ganga Ram Hospital, Delhi, India /
Thomas J. Vogl
University Hospital Frankfurt, Johann Wolfgang Goethe University, Germany /
Ya-Ping Xu
Shanghai Pulmonary Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:30-14:42 |
A New Field of Interventional Radiology: Breast Cancer Treatment |
Shinichi Hori | Institute for Image Guided Therapy, Japan |
2 | 14:42-14:54 |
Translational Research in Breast Cancers Metabolism |
Hai Hu | Zhejiang Cancer Hospital, China |
3 | 14:54-15:06 |
Evolution of Antibody-drug-conjugate Therapy for Breast Cancer |
Masakazu Toi | Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan |
4 | 15:06-15:18 |
TBD |
Yong-Mei Yin | Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China |
5 | 15:18-15:30 |
Advances in Breast Cancer Ablation |
Jie Yu | Chinese PLA General Hospital, China |
6 | 15:30-15:45 |
Panelists
Yong-Mei Yin
Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China /
Hai-Peng Yu
Tianjin Medical University Cancer Institute & Hospital, China /
Hai Hu
Zhejiang Cancer Hospital, China /
Masakazu Toi
Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan /
Jie Yu
Chinese PLA General Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:12 |
Contemporary Management of Locally Advanced Pancreas Cancer |
Flavio G. Rocha | Oregon Health and Science University, USA |
2 | 16:12-16:24 |
Precision Management of Pancreatic Cancer in the Era of Multimodal Analysis |
Bai-Yong Shen | Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China |
3 | 16:24-16:36 |
High-voltage Pulse Technology: From Fundamental Principles to Comprehensive Applications in Multiple Fields |
Zhong-Min Wang | Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China |
4 | 16:36-16:48 |
A Personalised Approach in the Treatment of Pancreatic Cancer |
Alexey Zhao | P. A. Herzen Institute of Oncology, Russia |
5 | 16:48-17:00 |
Panelists
Govindarajan Narayanan
Miami Cancer Institute Baptist Health South Florida, USA /
Flavio G. Rocha
Oregon Health and Science University, USA /
Bai-Yong Shen
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China /
Alexey Zhao
P. A. Herzen Institute of Oncology, Russia /
Zhong-Min Wang
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 17:00-17:12 |
Clinical Outcomes of Ablation-osteoplasty-reinforcement-internal Fixation (AORIF) of the Peri-acetabular Metastases from Breast, Lung, Prostate, and Kidney |
Francis Lee | Yale School of Medicine, USA |
2 | 17:12-17:24 |
AI-integrated PTA Treatment |
Aichi Chien | David Geffen School of Medicine at UCLA, USA |
3 | 17:24-17:36 |
Tips and Tricks for Manipulation of Microcatheter |
Shinichi Hori | Institute for Image Guided Therapy, Japan |
4 | 17:36-17:48 |
Transarterial Chemoembolization in the Management of Hepatocellular Carcinoma: An Overview of Global Practices and Emerging Trends |
Tamana Marvin | Philippine Heart Center, Philippines |
5 | 17:48-18:00 |
Technology-enhanced Precision in MIS HPB Surgery |
Alfred Kow Wei Chieh | National University Hospital, Singapore |
6 | 18:00-18:15 |
Panelists
Song Wang
The Affiliated Hospital of Qingdao University, China /
Francis Lee
Yale School of Medicine, USA /
Gao-Feng Shu
Zhejiang Lishui Central Hospital, China /
Aichi Chien
David Geffen School of Medicine at UCLA, USA /
Shinichi Hori
Institute for Image Guided Therapy, Japan /
Tamana Marvin
Philippine Heart Center, Philippines /
Alfred Kow Wei Chieh
National University Hospital, Singapore
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:42 |
Emerging Trends in the Treatment of Advanced Hepatocellular Carcinoma: A Radiological Perspective |
Hyun Ki Yoon | Asan Medical Center, University of Ulsan College of Medicine, Korea |
2 | 13:42-13:54 |
Value Based Care in IR Treatments of Hepatocellular Carcinoma |
Kiang Hiong Tay | Singapore General Hospital, Singapore |
3 | 13:54-14:06 |
MRI-guided Clinically Bacteriplytic Transarterial Embolization for Liver Tumor Therapy |
Zhuo-Li Zhang | University of California, USA |
4 | 14:06-14:18 |
Biomaterials to Assist Interventional Cancer Therapies |
Zhuang Liu | Soochow University, China |
5 | 14:18-14:30 |
Panelists
Lei Zhang
Sun Yat-sen Memorial Hospital, China /
Hong-Shan Zhong
China Medical University, China /
Hyun Ki Yoon
Asan Medical Center, University of Ulsan College of Medicine, Korea /
Kiang Hiong Tay
Singapore General Hospital, Singapore /
Zhuo-Li Zhang
University of California, USA /
Zhuang Liu
Soochow University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:30-14:42 |
Development and Application of Early Screening and Diagnosis Technology for Gastric Cancer |
Xiang-Dong Cheng | Zhejiang Cancer Hospital, China |
2 | 14:42-14:54 |
Advancing Y-90 Dosimetry: Personalized Approaches for Hepatocellular Carcinoma |
Jon C. Davidson | University Hospitals Cleveland Medical Center, USA |
3 | 14:54-15:06 |
Surgical Resection with Major Hepatic Vein Reconstruction for Colorectal Liver Metastasis |
Kiyoshi Hasegawa | Graduate School of Medicine, The University of Tokyo Hospital, Japan |
4 | 15:06-15:18 |
Ablation of Liver Cancer: Challenges and Developments |
Ming Kuang | The First Affiliated Hospital, Sun Yat-Sen University, China |
5 | 15:18-15:30 |
Panelists
Fei Gao
Sun Yat-Sen University Cancer Center, China /
Prijo Sidipratomo
Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Indonesia /
Xiang-Dong Cheng
Zhejiang Cancer Hospital, China /
Jon C. Davidson
University Hospitals Cleveland Medical Center, USA /
Wei-Ling He
Xiamen University Affiliated Xiang'an Hospital, China /
Kiyoshi Hasegawa
Graduate School of Medicine, The University of Tokyo Hospital, Japan
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:12 |
Different Response Pattern between IO plus Anti-VEGF and IO plus IO Regimens |
Masatoshi Kudo | Kindai University Faculty of Medicine, Japan |
2 | 16:12-16:24 |
Mechanistic Research and Emerging Therapeutic Approaches for Hepatocellular Carcinoma with Pulmonary Metastasis |
Hong Wu | West China Hospital of Sichuan University, China |
3 | 16:24-16:36 |
Combining TACE with Checkpoint Inhibitors for Intermediate-Stage HCC |
Jon C. Davidson | University Hospitals Cleveland Medical Center, USA |
4 | 16:36-16:48 |
Chinese Experience of Perioperative Management for Liver Cancer |
Hong Zhao | Cancer Institute and Hospital, China |
5 | 16:48-17:00 |
Panelists
Hong Wu
West China Hospital of Sichuan University, China /
Le-Du Zhou
Xiangya Hospital of Central South University, China /
Masatoshi Kudo
Kindai University Faculty of Medicine, Japan /
Jon C. Davidson
University Hospitals Cleveland Medical Center, USA /
Hong Zhao
Cancer Institute and Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 17:00-17:12 |
Multimodal Therapies and Emerging Insights in Colorectal Cancer Liver Metastases |
Wei-Ling He | Xiamen University Affiliated Xiang'an Hospital, China |
2 | 17:12-17:24 |
Advancements in Irreversible Electroporation Techniques for Kidney Tumors |
Tze Min Wah | St. James's University Hospital, UK |
3 | 17:24-17:36 |
The Evolution of Irreversible Electroporation: Insights from a Decade of Practice |
Govindarajan Narayanan | Miami Cancer Institute Baptist Health South Florida, USA |
4 | 17:36-17:48 |
Microwave Ablation for Large Tumors: Techniques to Minimize Recurrence |
Jon C. Davidson | University Hospitals Cleveland Medical Center, USA |
5 | 17:48-18:00 |
Panelists
Masakazu Toi
Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan /
Yong-Yi Zeng
The First Affiliated Hospital of Fujian Medical University, China /
Ming Kuang
The First Affiliated Hospital, Sun Yat-Sen University, China /
Tze Min Wah
St. James's University Hospital, UK /
Govindarajan Narayanan
Miami Cancer Institute Baptist Health South Florida, USA /
Jon C. Davidson
University Hospitals Cleveland Medical Center, USA
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:42 |
The Application of AI in HPB Surgery and Oncology |
Alfred Kow Wei Chieh | National University Hospital, Singapore |
2 | 13:42-13:54 |
A Duo-targeting Pan-anticancer Strategy with Potential Interventional Applications |
Yi-Cheng Ni | Southeast University, China |
3 | 13:54-14:06 |
New Data Showing Vascular Changes in Patients with Diabetes: How to Modify Treatment Strategies |
Aichi Chien | David Geffen School of Medicine at UCLA, USA |
4 | 14:06-14:18 |
ALPPS--New Surgical Paradigm to Treat Traditionally-Unresectable Liver Cancer |
Jian Zhou | Zhongshan Hospital, Fudan University, China |
5 | 14:18-14:30 |
Panelists
Guang-Hui Luo
Kiang Wu Hospital, Macau, China /
Han Wang
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, China /
Alfred Kow Wei Chieh
National University Hospital, Singapore /
Yi-Cheng Ni
Southeast University, China /
Aichi Chien
David Geffen School of Medicine at UCLA, USA /
Jian Zhou
Zhongshan Hospital, Fudan University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:30-14:42 |
Lymphangiography and TD Embolization in Latrogenic Chylous Leaks |
Ajit K. Yadav | Sir Ganga Ram Hospital, Delhi, India |
2 | 14:42-14:54 |
MRI-guided IRE Combined with DC Vaccination for PDAC Treatment |
Zhuo-Li Zhang | University of California, USA |
3 | 14:54-15:06 |
Molecular Imaging Biomarker Development for Combined Immunotherapy and Locoregional Therapy of HCC: From Bench to Bedside |
Julius Chapiro | Yale School of Medicine, USA |
4 | 15:06-15:18 |
Comprehensive TAE Strategy for HCC Based on Thermo-Sensitive Nanogels |
Xiang-Liang Yang | Huazhong University of Science and Technology, China |
5 | 15:18-15:30 |
Towards Precision Medicine: Multi-modal Image Analysis Driven by Artificial Intelligence |
Yang Wang | Zhejiang Cancer Hospital, China |
6 | 15:30-15:45 |
Panelists
Francis Lee
Yale School of Medicine, USA /
Rui-Fang Ni
The First Affiliated Hospital of Soochow University, China /
Ajit K. Yadav
Sir Ganga Ram Hospital, Delhi, India /
Zhuo-Li Zhang
University of California, USA /
Xiang-Liang Yang
Huazhong University of Science and Technology, China /
Julius Chapiro
Yale School of Medicine, USA /
Yang Wang
Zhejiang Cancer Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:10 |
Opening Remarks
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
2 | 16:10-16:25 |
Cryoablation for Locally Advanced Pancreatic Cancer and Pancreatic Metastasis |
Alexey Zhao | P. A. Herzen Institute of Oncology, Russia |
3 | 16:25-16:40 |
Interventional Treatments for Benign and Malignant Breast Masses |
Mehmet Mahir Atasoy | Maltepe University School of Medicine, Turkey |
4 | 16:40-16:55 |
Cryoablation in the Prostate |
Saim Yilmaz | Varisson Radiology Center, Turkey |
5 | 16:55-17:10 |
The role of Thermal Ablation Methods in the Treatment of HCC in the Republic of Kazakhstan |
Niyaz Malayev | National Scientific Medical Center, Kazakhstan |
6 | 17:10-17:25 |
Role of Interventional Radiology in Pain Management of Abdominal Cancer |
Shahzad Bhatti | Mayo Hospital/King Edward Medical University, Pakistan |
7 | 17:25-17:40 |
Co-ablation System in Tumor Therapy: Advancements in Composite Cryo-thermal Ablation for Cancer Treatment |
Li-Zhi Niu | Guangzhou Fuda Cancer Hospital, China |
8 | 17:40-17:55 |
Discussion
Wei-Jun Fan
Sun Yat-sen University Cancer Center, China /
Zhong-Min Wang
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China
|
||
9 | 17:55-18:00 |
Conference Summary
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:42 |
New Ice Age of Musculoskeletal Intervention: Role of Percutaneous Cryoablation in Bone and Soft Tissue Tumors |
Jun-Jian Huang | Emory University school of medicine, USA |
2 | 13:42-13:54 |
Super-selective TACE |
Seung Boo Yang | Nowon Eulji University Hospital, Korea |
3 | 13:54-14:06 |
Optimizing Outcomes in Centrally Located HCC: The Evolving Role of Precision Radiotherapy |
Wei-Hu Wang | Beijing Cancer Hospital, China |
4 | 14:06-14:18 |
From Vision to Precision: Image-guided Solutions for Interventional Oncology |
Yu Deuerling Zheng | Siemens Healthineers, Germany |
5 | 14:18-14:30 |
Panelists
Hai-Bin Shi
Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China /
Jun-Jian Huang
Emory University school of medicine, USA /
Seung Boo Yang
Nowon Eulji University Hospital, Korea /
Wei-Hu Wang
Beijing Cancer Hospital, China /
Yu Deuerling Zheng
Siemens Healthineers, Germany
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:30-14:45 |
Transradial HepaSphere Treatment for HCC in AMC |
Ji Hoon Shin | Asan Medical Cente, University of Ulsan College of Medicine, Korea |
2 | 14:45-15:00 |
Combined Immuno-DTACE for Difficult-to-treat Liver Cancer Patients |
Alex Tang | Subang Jaya Medical Centre,Malaysia |
3 | 15:00-15:15 |
Advancing Your Practice in Refractory Liver Cancers Management |
Shinichi Hori | Institute for Image Guided Therapy, Japan |
4 | 15:15-15:30 |
Discussion
Jia-Ping Li
The First Affiliated Hospital of Sun Yat-sen University, China /
Zi-Shu Zhang
Xiangya Hospital Central South University, China /
Hai-Bo Shao
The First Affiliated Hospital of China Meical University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:06 |
Does Needle Biopsy Immediately after Percutaneous Microwave and Cryoablation of Lung Neoplasm Affect Pathological Results? A Clinical and Animal Study |
Jun-Ting Ma | First Hospital of China Medical University, China |
2 | 16:06-16:12 |
Outcomes of First-line Microwave Ablation of Treatment-naive Epidermal Growth Factor Receptor–mutated Advanced Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitors |
Sheng Xu | Beijing Hospital, National Center of Gerontology, China |
3 | 16:12-16:18 |
Microwave Ablation versus Lobectomy for Ground-glass Opacity Nodules in the Hilar Region: A Multicenter Prospective Real-world Study on Efficacy and Safety |
Jia-Chang Chi | renji hospital, China |
4 | 16:18-16:24 |
Cryoablation Enhanced Anti-tumor Immunity and Survival for Patients with Liver Metastatic Melanoma Receiving PD-1 Blockade Therapy: Insights from Longitudinal RNA-seq Data |
Chen Li | Sun Yat-sen University Cancer Center, China |
5 | 16:24-16:30 |
Response Evaluation of Liver Directed Therapies for Liver Metastasis in NET |
VARSHA KEDAR | TATA MEMORIAL HOSPITAL, MUMBAI , INDIA |
6 | 16:30-16:36 |
Hepatic Arterial Infusion Chemotherapy with or without Hepatic Artery Chemoembolization for Esophageal Carcinoma Patients with Liver Metastasis: A Clinical Retrospective Study |
Mingrui Yan | Peking University Shougang Hospital,Beijing, China |
7 | 16:36-16:42 |
Drug Eluting Bead Transarterial Chemoembolization (DTACE) Combined with Hepatic Arterial Infusion Chemotherapy versus DTACE Alone for Hepatocellular Carcinoma in Barcelona Clinic Liver Cancer stage C: A Prospective, Multicenter Analysis |
Daqian Han | The First Affiliated Hospital of Zhengzhou University |
8 | 16:42-16:48 |
Comparing Percutaneous and Endoscopic Biliary Drainage in Inoperable Bismuth III/IV Malignant Hilar Biliary Obstruction: Clinical Outcomes and Prognostic Factors |
XIAO-BO FU | Sun Yat-sen University Cancer Center, China |
9 | 16:48-16:54 |
Metformin Suppress Liver Cancer Metastasis by Inhibiting Microwave Ablation Therapy Induced EMT through Modulation of the TGF-β-Smad2/3 Signaling Pathway |
Xian-Mei Liu | Affiliated Hospital of Guizhou Medical University, China |
10 | 16:54-17:00 |
Health Economics Analysis of Three Treatment Methods for Uterine Fibroids |
Yong Jin | The Second Affiliated Hospital of Soochow University, China |
11 | 17:00-17:06 |
Percutaneous Transhepatic Cholangiography in Biliary Obstruction: A Retrospective Audit of Outcomes and Complications |
Sana Sheykhzadeh | Norfolk and Norwich University Hospital |
12 | 17:06-17:12 |
Retrospective Analysis of Diagnostic Accuracy of Image-guided Needle Biopsy of Pancreatic Lesions |
Antariksh Vijan | Tata Memorial Hospital, Mumbai, India |
13 | 17:12-17:18 |
CCL2⁺ Inflammatory Cancer-associated Fibroblasts Promote Chemoresistance and Tumor Progression in Microsatellite Stable Colorectal Cancer via the CCL2-P4HB-NOTCH-STAT3 Axis |
Si-Yuan Weng | National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, China |
14 | 17:18-17:24 |
3D-printed Versatile Biodegradable Biliary Stent with Zinc/Sirolimus for Anti-bacterial and Anti-hyperplasia in a Rabbit Bile Duct |
Jung-Hoon Park | Asan Medical Center, Korea |
15 | 17:24-17:30 |
Neoadjuvant Arterial Infusion Chemotherapy versus Intravenous Chemotherapy for Locally Advanced Gastric Cancer: A Long-term Follow-up |
Jun Chen | Zhejiang Provincial People's Hospital, Hangzhou Medical College, China |
16 | 17:30-17:36 |
Whether the Choice of Location for Re-implantation Chest Port Affects the Incidence of Complications in Adult Tumor Patients Undergoing Right Chest Port Removal |
Cao-Ye Wang | Changzhou First People Hospital, China |
17 | 17:36-17:42 |
Direct Percutaneous Embolization of Hypervascular Renal Cell Cancer Metastasis to the Spine |
Calvin Cheong | National University Hospital, Singapore |
18 | 17:42-17:48 |
Long-term Outcomes of Image-guided Ablation and Laparoscopic Partial Nephrectomy for T1 Renal Cell Carcinoma |
Vinson Chan | University of Leeds, United Kingdom |
19 | 17:48-17:54 |
The Status of Cytotoxic Lymphocytes Indicate Therapeutic Efficacy and Prognosis in Patients with Advanced Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Systemic Therapies |
Hai-Feng Zhou | The First Affiliated Hospital of Nanjing Medical University, China |
20 | 17:54-18:00 |
Transjugular Intrahepatic Portosystemic Shunt Plus Transarterial Chemoembolization of Hepatocellular Carcinoma Patients with Portal Vein Tumour Thrombus-related Variceal Bleeding |
Wei-Zhong Zhou | The first affiliated hospital of Nanjing medical university, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:35 |
Welcome Address
Sheng-Hong Ju
Zhongda Hospital, Southeast University, China
|
||
2 | 13:35-13:40 |
ROADS Launch Ceremony |
||
3 | 13:40-14:05 |
How to Evaluate Treatment Response of HCC after Radiation Based Locoregional Treatment: LR-TRA v2024 |
Jeong Min Lee | Seoul National University Hospital, Korea |
4 | 14:05-14:30 |
Recent Advances in Image-Guided Locoregional Therapies for HCC (New Navigation Tools, New Devices, New Techniques) |
Roberto Iezzi | Università Cattolica del Sacro Cuore, Italy |
5 | 14:30-14:55 |
MRI at 0.05 Tesla: A Computing-powered Point-of-care Imaging Device? |
Ed X. Wu | The University of Hong Kong, China |
6 | 14:55-15:20 |
Use of EOB MRI for Imaging of Hepatic Malignancies |
Cher Heng Tan | Tan Tock Seng Hospital, Singapore |
7 | 15:20-15:35 |
Coffee Break |
||
8 | 15:35-16:00 |
Infiltrative HCC: What Every Radiologist Needs to Recognize and Report |
Sahat Matondang | Cipto Mangunkusumo National General Hospita, Indonesia |
9 | 16:00-16:25 |
Hepatocellular Carcinoma beyond Diagnosis: Role of Imaging in Prognostication, Pathology and Genetic Correlation |
Xiao-Yang Liu | The University of Toronto, Canada |
10 | 16:25-16:50 |
Imaging Evalution of the Treatment Response after Locoregional Therapy for HCC |
Yuan-Cheng Wang | Zhongda Hospital, Southeast University, China |
11 | 16:50-17:30 |
ROADS Abdominal Imaging Case Review Webinar |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:35 |
Opening Speakers
Gao-Jun Teng
Zhongda Hospital, Southeast University, China /
Masatoshi Kudo
Kindai University Faculty of Medicine, Japan /
Jian Zhou
Zhongshan Hospital, Fudan University, China
|
||
2 | 13:35-13:40 |
ISMIO Meets APPLE: International Consensus Project on TACE Combined with Targeted Therapy and Immunotherapy for HCC
Gao-Jun Teng
Zhongda Hospital, Southeast University, China /
Masatoshi Kudo
Kindai University Faculty of Medicine, Japan /
Jian Zhou
Zhongshan Hospital, Fudan University, China /
Lian-Xin Liu
The First Affiliated Hospital of University of Science and Technology of China /
Feng Shen
Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China /
Ming Kuang
The First Affiliated Hospital, Sun Yat-Sen University, China /
Hong Wu
West China Hospital of Sichuan University, China
|
||
3 | 13:40-14:00 |
Panel Discussion: CNLC Meets BCLC: Impact of TACE-Targeted-Immunotherapy Advances on International Guideline Updates: Evidence from Global Trials and Clinical Practice
Gao-Jun Teng
Zhongda Hospital, Southeast University, China /
Masatoshi Kudo
Kindai University Faculty of Medicine, Japan /
Jian Zhou
Zhongshan Hospital, Fudan University, China /
Lian-Xin Liu
The First Affiliated Hospital of University of Science and Technology of China /
Feng Shen
Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China /
Ming Kuang
The First Affiliated Hospital, Sun Yat-Sen University, China /
Hong Wu
West China Hospital of Sichuan University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 08:00-08:12 |
TBD |
Dong Xu | Zhejiang Cancer Hospital, China |
2 | 08:12-08:24 |
TBD |
Hui-Xiong Xu | Zhongshan Hospital, Fudan University, Shanghai, China |
3 | 08:24-08:36 |
Ablation of Papillary Microcacinoma |
Mehmet Korkmaz | Evliya Çelebi Training & Research Hospital, Turkey |
4 | 08:36-08:48 |
Ablation of Parathyroid Adenomas |
Furkan Erturk Urfali | Bursa City Hospital, Turkey |
5 | 08:48-09:00 |
Surgical Perspectives on Thyroid Anatomy and Strategies for Ablative Treatment of Benign and Malignant Tumors |
Ying Zhou | The First Affiliated Hospital of Hebei University of Chinese Medicine, China |
6 | 09:00-09:12 |
The Role of URM in the Differential Diagnosis of Benign and Malignant Cervical Lymph Nodes: A Preliminary Study |
Ji-Ye Chen | Zhejiang Cancer Hospital, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 09:30-09:36 |
Preparation of a Composite Nanozyme and Its Sonodynamic Therapy in Bladder Cancer |
Jia-Jia Zheng | Zhejiang Provincial People‘s Hospital, China |
2 | 09:36-09:42 |
Trans-arterial Embolisation Prior to Image-guided Ablation for T1b/T2a Renal Masses – A Systematic Review and Meta-analysis |
Aisha Ahmed | University of Leeds |
3 | 09:42-09:48 |
Multicentre Real World Outcomes of Irreversible Electroporation for Complex Small Kidney Cancers (REWIRED) |
Vinson Chan | University of Leeds, United Kingdom |
4 | 09:48-09:54 |
Results of Ultrasound Guided Vacuum Assisted Breast Biopsy Treatment for Benign Breast Tumor |
Batmunkh Erdenebulgan | Second state central hospital, Mongolia |
5 | 09:54-10:00 |
A Nomogram Predicting Venous Thromboembolism Risk in Primary Liver Cancer Patients |
Jing Xiao | Chongqing University Cancer Hospital, China |
6 | 10:00-10:06 |
Breat Thermogram Database Generation to Use AI for Early Breast Cancer Detection |
Bilal Majeed | University of Limerick |
7 | 10:06-10:12 |
Irradiation Modulates sEVs-PD-L1 Transport in TNBC's Tumor Immune Microenvironment |
Yuqin Wei | Wuming Hospital of Guangxi Medical University, China |
8 | 10:12-10:18 |
A Real-world Survey of 1830 Surviving Patients with Adamantinomatous Craniopharyngioma in China |
Zhi-Xiong Lin | Sanbo Brain Hospital, Capital Medical University, China |
9 | 10:18-10:24 |
The Diversity of Arterial Approaches in Delivering Intra-arterial Chemotherapy for Retinoblastoma: Experiences from Indonesia |
Jason Jason | Department of Radiology, Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia |
10 | 10:24-10:30 |
Comparative Effectiveness of Liquid versus Solid Embolic Agents in Pre-surgical Embolization for Intracranial Tumors: A Systematic Review and Meta-analysis |
Yuhang Zhao | Zhongda Hospital, Medical School, Southeast University, China |
11 | 10:30-10:36 |
Percutaneous Catheter Drainage (PCD) as Primary Treatment for Necrotizing Pancreatitis: Clinical Outcomes and Comparative Effectiveness |
Gantulga Vanchinsuren | Second State Center Hospital |
12 | 10:36-10:42 |
Analysis of Short and Medium Term Clinical Effect of Prostatic Artery Embolization on Symptomatic Prostatic Hyperplasia |
Shi-Long Han | Tenth People's Hospital of Tongji University, China |
13 | 10:42-10:48 |
Role of Sclerotherapy in Patients with Vascular Malformations - A Retrospective Study |
Anand Agrawal | |
14 | 10:48-10:54 |
Single-cell RNA Sequencing Identifies the Versican-producing Cells in Tumor Microenvironment of Cervical Cancer |
Meng-Fan Zhang | First Affiliated Hospital of Zhengzhou University, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 08:00-08:06 |
CT-Guided Microwave Ablation with Vertebral Augmentation for Spinal Metastases with Posterior Wall Defects |
Kai-Xian Zhang | Tengzhou Central People’s Hospital, China |
2 | 08:06-08:12 |
A Novel Silver Nanoparticles-functionalized Stent for the Treatment of Malignant Stricture of Esophagus |
Yan Fu | National cancer hospital, Beijing, China |
3 | 08:12-08:18 |
Mitochondrial-Cytosolic Cascade Metabolic Regulation System: A Robust Strategy to Disrupt Multipath Energy Replenishment in Cancer Therapy |
Tian-Ming Wang | Xiangya Hospital, Central South University, China |
4 | 08:18-08:24 |
Prevention of Acute Thrombosis with Vascular Endothelium Antioxidative Nanoscavenger |
Yi-Xin Zhong | Southeast University Affiliated Zhongda Hospital, China |
5 | 08:24-08:30 |
Idarubicin-loaded Degradable Hydrogel for TACE Therapy Enhances Anti-tumor Immunity in Hepatocellular Carcinoma |
Xiao-Kai Zhang | Henan Cancer Hospital/ Affiliated Cancer Hospital of Zhengzhou University, China |
6 | 08:30-08:36 |
The Eight Mitochondrial Metabolism-related Genes as Diagnostic Markers for Abdominal Aortic Aneurysm by Integrating Machine Learning Approach |
Yang Zheng | Chongqing University Cancer Hospital |
7 | 08:36-08:42 |
Functionalized Calcium Alginate Microspheres for TACE Immunotherapy via Polarizing Macrophages and Releasing Anti-tumor Immune Exosomes |
Xiao-Ju Guo | Lishui Central Hospital, China |
8 | 08:42-08:48 |
Celecoxib and Cisplatin Dual-loaded Microspheres Synergistically Enhance Transarterial Chemoembolization Effect of Hepatocellular Carcinoma |
Xin-Wei Han | The First Affiliated Hospital of Zhengzhou University, China |
9 | 08:48-08:54 |
Synergistic Quad-modal Nanoembolics: pH/NIR-Driven Chemo-photothermal Ablation with Immune Reprogramming for HCC |
Wan-Qing Shen | the first affiliated hospital of sun yat-sen university, China |
10 | 08:54-09:00 |
Restraining Small Extracellular Vesicles: Dawn of A New Era in Nanomedicine |
Ming Yang | Zhongda Hospital, Southeast University, China |
11 | 09:00-09:06 |
Engineered Macrophage Membrane-mimicking Nanodrugs Activate the cGAS/STING Pathway to Reverse the Immune-suppressive Microenvironment Induced by RFA |
Wei-Hua Zhang | Southeast University, China |
12 | 09:06-09:12 |
Development and Functional Research of an Irradiation-cytokine Composite Stent for Modulating Immune Microenvironment Reprogramming |
Juan Qin | Zhongda Hospital, Medical School, Southeast University, China |
13 | 09:12-09:18 |
Tailored Liposomal Nanomedicine Suppresses Incomplete Radiofrequency Ablation-induced Tumor Relapse by Reprogramming Antitumor Immunity |
Duo Wang | zhongda hospital, southeast university, China |
14 | 09:18-09:24 |
Autocatalytic Pyroptosis Agonists Modulate Tumor Metabolism and Enhance TACE Efficacy in HCC Therapy |
Lin-Zhu Zhang | Zhongda Hospiital, Southeast University, China |
15 | 09:24-09:30 |
Injectable Hydroxyapatite Radiopaque Microspheres: The Next-generation Material for Cancer Interventional Embolization? |
Yi-Nan Ding | sciences zhejiang cancer hospital, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 09:30-09:36 |
First-in-Human Study of an Artificial Intelligence Integrated Robot for Image-Guided, Trans-Thoracic Lung Biopsy under Local Anaesthesia |
Nadia Rojas | Singapore General Hospital, Singapore |
2 | 09:36-09:42 |
Cancer-Associated Fibroblasts-Derived SEMA3C Facilitates Colorectal Cancer Liver Metastasis via NRP2-Mediated MAPK Activation. |
Yuyuan Zhang | The First Affiliated Hospital of Zhengzhou University, China |
3 | 09:42-09:48 |
Global Interest of Interventional Radiology and Interventional Oncology: A Review of a Decade Using The Google Trends Platform |
Vinson Chan | University of Leeds, United Kingdom |
4 | 09:48-09:54 |
Quantification of Habitat Imaging Combined with Peritumoral Microenvironment Evolution for Predicting Extracapsular Extension in Prostatic Cancer |
Ye Xiang | Leshan Hospital,Chengdu University of TCM, China |
5 | 09:54-10:00 |
Harmonizing Ancient Wisdom and Modern Technology: Exploring Retrieval-Augmented Generation (RAG) with Large Language Models to Transform Education in Interventional Oncology |
Hassan Magdy | Gastrointestinal Surgery Center, Mansoura University, Egypt |
6 | 10:00-10:06 |
Conventional Oral Morphine vs. IV Patient-Controlled Analgesia (IPCA) with Hydromorphone (HM) Continuous Infusion plus Rescue Dose (CIRD) or Bolus-Only (BO) for Severe Cancer Pain: A Randomized Phase III study |
Liyu Su | Fujian Cancer Hospital, China |
7 | 10:06-10:12 |
Efficacy Comparison of Liver Venous Deprivation and TACE Combined with Targeted and Immunotherapies in Unresectable Hepatocellular Carcinoma with Insufficient FLR Volume |
Ying Yang | West China Hospital, Sichuan University, China |
8 | 10:12-10:18 |
Spatial Transcriptomics Reveals Tryptophan Metabolism Restricting Maturation of Intratumoral Tertiary Lymphoid Structures |
Shuling Chen | The First Affiliated Hospital of Sun Yat-sen University, China |